- Report
- August 2023
- 51 Pages
Spain
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Israel
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Colombia
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
South Africa
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Germany
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
France
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Turkey
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Canada
From €570EUR$600USD£479GBP
- Report
- November 2023
- 190 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2020
- 452 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2024
- 95 Pages
Global
From €3500EUR$3,944USD£3,043GBP

The Self Monitoring Blood Glucose (SMBG) Devices market is a subset of the larger Glucose Testing market. SMBG Devices are used to measure and monitor blood glucose levels in individuals with diabetes. These devices are typically small, handheld, and battery-powered, and allow users to quickly and easily measure their glucose levels. SMBG Devices are often used in conjunction with other diabetes management tools, such as insulin pumps and continuous glucose monitors.
SMBG Devices are typically used by individuals with diabetes to monitor their glucose levels on a regular basis. This helps them to better manage their diabetes and reduce the risk of complications. Additionally, SMBG Devices can be used to detect hypoglycemia, or low blood sugar, which can be dangerous if left untreated.
Some companies in the SMBG Devices market include Abbott, Roche, LifeScan, and B. Braun. Show Less Read more